What We're Reading: Page 289
Industry reads hand-picked by our editors
Sep 01, 2017
Aug 31, 2017
Aug 30, 2017
-
Financial Times
Open borders key to Swiss pharma’s EU success
-
Bloomberg
ETF investors arrive just in time to get a slice of an $11.9 billion biotech deal
-
The San Diego Union-Tribune
Green card policy change could affect San Diego biotech companies
Aug 29, 2017
-
Forbes
What can a company justifiably charge for a cancer cure?
-
Bloomberg Businessweek
Medical journals have a fake news problem
-
Reuters
Bristol-Myers, Daiichi Sankyo to test Opdivo combo for cancers
Aug 28, 2017
-
International Business Times
How big pharma secretly funds the fight to keep drug prices high
-
Kaiser Health News
Offshore rush for herpes vaccine roils debate over U.S. safety rules
-
The Guardian
Could a heroin vaccine cure the west’s drug epidemic?
Aug 25, 2017
Aug 24, 2017
-
Kaiser Health News
‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost
-
Science
A bold open-access push in Germany could change the future of academic publishing
-
Healthcare Dive
Intermountain plans to cut opioid prescriptions by 40%
-
Regulatory Focus
Patients not always informed of study's purpose in noninferiority trials
Previous
